Form 4 Filing for Michelle Kumbier

Michelle Kumbier, a director at Abbott Laboratories, was granted 2,286 restricted stock units on April 24, 2026. This award, granted under the company's 2026 Incentive Stock Program, will vest and be paid out on a one-to-one basis in Abbott common shares. The payout will occur on the earliest of the director's separation from service, death, or a change in control, as defined by the Program. Following this transaction, Ms. Kumbier holds 18,000 shares. Additionally, a power of attorney document was filed, appointing attorneys to prepare and file necessary forms with the SEC on Ms. Kumbier's behalf, including those related to Rule 144 and Section 16(a) of the Securities Exchange Act. This authorization remains in effect until Ms. Kumbier is no longer required to make such filings or revokes the authorization.